soul trial oral semaglutide cardiovascular outcomes 2024 results nejm of and tirzepatide for patients with type 2 diabetes in clinical practice soul trial oral semaglutide cardiovascular

GIP showed a diminished effect in boosting insulin secretion in T2D patients, for reasons that are still not understood

Those with heart or kidney disease should follow their healthcare provider's specific advice about fluid intake

PlexusDx patients receive detailed storage instructions with every shipment to ensure optimal medication performance

READ NEXT: How Functional Medicine Can Support Weight Loss Final Thoughts On Ozempic and Eye Disease Overall, my takeaway when it comes to Ozempic and eye problems is that there is clearly a risk and that we also need to pay attention to how a treatment is being used, not just what it is

All the deaths were adjudicated by an external committee of physicians